Evidence map›Paper›PMID 34204950›Full record

ArticleInternational journal of molecular sciences2021

Eva Jiménez-Mora, Beatriz Gallego, Sergio Díaz-Gago, Marina Lasa, Pablo Baquero, Antonio Chiloeches

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Reprogramming of fatty acid metabolism in thyroid cancer: Potential targets and mechanisms.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2025
    Article
  5. Review
  6. Article
  7. MicroRNA-mediated autophagy regulation in thyroid cancer drug resistance.Cancer drug resistance (Alhambra, Calif.) · 2025
    Review
  8. CLDN6 induces chemoresistance through protective autophagy in breast cancer.International journal of biological sciences · 2025
    Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Non-Apoptotic Programmed Cell Death in Thyroid Diseases.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  15. Recent Advances in Thyroid Cancer Research.International journal of molecular sciences · 2022
    Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Eva Jiménez-MoraDepartamento de Biología de Sistemas, Unidad de Bioquímica y Biología Molecular, Facultad de Medicina, Campus Universitario, Universidad de Alcalá, Alcalá de Henares, 28871 Madrid, Spain.
Beatriz GallegoDepartamento de Biología de Sistemas, Unidad de Bioquímica y Biología Molecular, Facultad de Medicina, Campus Universitario, Universidad de Alcalá, Alcalá de Henares, 28871 Madrid, Spain.ORCID 0000-0002-7240-7200
Sergio Díaz-GagoDepartamento de Biología de Sistemas, Unidad de Bioquímica y Biología Molecular, Facultad de Medicina, Campus Universitario, Universidad de Alcalá, Alcalá de Henares, 28871 Madrid, Spain.
Marina LasaDepartamento de Bioquímica-Instituto de Investigaciones Biomédicas "Alberto Sols", Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Científicas, 28029 Madrid, Spain.ORCID 0000-0003-2245-3943
Pablo BaqueroDepartamento de Biología de Sistemas, Unidad de Bioquímica y Biología Molecular, Facultad de Medicina, Campus Universitario, Universidad de Alcalá, Alcalá de Henares, 28871 Madrid, Spain.
Antonio ChiloechesDepartamento de Biología de Sistemas, Unidad de Bioquímica y Biología Molecular, Facultad de Medicina, Campus Universitario, Universidad de Alcalá, Alcalá de Henares, 28871 Madrid, Spain.ORCID 0000-0001-7162-330X
Universidad de Alcalá · ESConsejo Superior de Investigaciones Científicas · ES

Funding

Ministerio de Ciencia, Innovación y Universidades of Spain SAF 2014-53639-RUniversidad de Alcalá CM/JIN/2019-019
6 · The paper itself

Abstract

The dysregulation of autophagy is important in the development of many cancers, including thyroid cancer, where

Indexed as

AMP-Activated Protein Kinase KinasesApoptosisAutophagyAutophagy-Related Protein-1 HomologCell Line, TumorCell ProliferationCell SurvivalGene Expression Regulation, NeoplasticHumansIndolesIntracellular Signaling Peptides and ProteinsMutationProtein Kinase InhibitorsProtein KinasesProtein Serine-Threonine KinasesProto-Oncogene Proteins B-rafAMP-Activated Protein Kinase KinasesAutophagy-Related Protein-1 HomologBRAF protein, humanIndolesIntracellular Signaling Peptides and ProteinsPLX 4720Protein Kinase InhibitorsProtein KinasesProtein Serine-Threonine KinasesProto-Oncogene Proteins B-rafRNA, Small InterferingSTK11 protein, humanSulfonamidesULK1 protein, humanAMPKautophagyLKB1survivalthyroid cancerULK1V600EBRAF

Identifiers

PMID34204950
PMCPMC8199856
OpenAlexW3166601997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.